2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary SyndromesSunil V. Rao, Frederick G.P. Welt, Michelle L. O’Donoghue et al.|Journal of the American College of Cardiology|2025Cited by 346
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trialJean‐Claude Tardif, Guy Boivin, Martin Pelletier et al.|The Lancet Respiratory Medicine|2021Cited by 271
Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular DiseasePhilip C. Robinson, Mark Nidorf, Robert Terkeltaub et al.|The American Journal of Medicine|2021Cited by 122
Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery DiseasePamela S. Douglas, Jane Cao, Michael G. Nanna et al.|JAMA Cardiology|2023Cited by 97
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trialsAernoud T.L. Fiolet, Peter J. Kelly, Michiel H.F. Poorthuis et al.|EClinicalMedicine|2024Cited by 56